- Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment PSP is a degenerative disease that, like Parkinson's disease, causes symptoms such ...

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced the dosing of the first participant in the Phase II clinical trial, PROSPER. The study ...

Q1 2026 Management View "Our optimism was validated by the recent FDA approval of vepdeg, now known as VEPPANU. And yesterday afternoon, we were pleased to announce that we and Pfizer have entered ...

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder ...

Progressive supranuclear palsy (PSP), a mysterious and deadly neurological disorder, usually goes undiagnosed until after a patient dies and an autopsy is performed. But now, UC San Francisco ...

(MENAFN- GetNews) The Key Progressive Supranuclear Palsy Companies in the market include - Woolsey Pharmaceutical, Asahi Kasei Pharma, AlzProtect, Amylyx Pharmaceuticals, Transposon Therapeutics, ...

For the past 20 years, Janet Edmunson has run support groups for patients with rare neurological diseases that have no known treatment or cure. What they want to know, Edmunson said, is "'When are ...

The inability to identify PSP has hampered the development of new treatments, according to co-senior author Adam Boxer, MD, PhD, endowed professor in memory and aging at the UCSF Department of ...